Launch of the National Drug-Related Deaths Index. by Lynn, Ena & Long, Jean
On 26 September 2005, government officials,
community organisations, service providers,
representatives of the Garda, along with the
media and other interested parties, gathered at
Ozanam House Community Resource Centre to
mark the launch of the National Drug-Related
Deaths Index. 
Mr David Moloney, principal officer at the
Department of Health and Children, welcomed
the audience and introduced the distinguished
panel of speakers, which included Mr Seán
Power TD, minister of state at the Department
of Health and Children, Mr Philip Keegan,
chairperson of the Family Support Network, and
Dr Jean Long, senior researcher at the Health
Research Board.
Speaking at the launch, Minister Power complimented the Family Support Network on its ongoing
work and affirmed his support for the establishment of the Index. The minister said: ‘The Index is
being established to help deliver one of the key aims of the National Drugs Strategy, which highlights
the need to gather better information about the drugs issue and responses to it.’ This initiative will
particularly address Action 67, which identifies the need to develop an accurate mechanism for
recording the number of drug-related deaths in Ireland.1 He said: ‘In many cases, the connection
between drug use and death may not be either identified or recorded. A death resulting from an
infectious disease contracted through drug misuse, for example, may not feature in the current
figures. There are clear concerns that our knowledge of the true cost of drug misuse through lost lives
is not as comprehensive as it should be. This new Index will be a significant step towards better
quality data and improved accuracy on the true cause of death.’
Mr Philip Keegan presented a brief history of the development of the Index. When compiling
background information for the first Service of Commemoration and Hope in November 2000, the
Family Support Network could not locate accurate numbers of drug-related deaths and deaths
among drug users. This was because the current system could only extract data on direct drug-
related deaths. Following the service, Dr Joe Barry, medical advisor to the National Drugs Strategy
Team, with the co-operation of parents, reviewed death certificates of their children who had died as
a result of drug use. This review found that many of the drug-related-deaths and deaths among drug
users were miscoded. A sub-group was subsequently set up to examine the prospect of establishing
an index to record drug-related deaths and a proposal was submitted to government in 2004. Mr
Keegan said that drug-related deaths and deaths among drug users were indicators of the
consequences of drug misuse in Ireland. He went on to suggest that the accurate recording of such
deaths would lead to more appropriate policy and planning. In addition, Mr Keegan called for
appropriate services for bereaved families, such as counselling provided by counsellors who have a
professional understanding of both addiction and bereavement.
Dr Jean Long presented a brief overview of what is currently known about drug-related deaths in
Ireland2 in the following key points:
■ The number of direct drug-related deaths increased in Ireland between 1996 and 2000 with the
majority of deaths occurring in Dublin. In 2001, there was a substantial decrease in the number
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of direct drug-related deaths in Dublin and a
continued increase in direct drug-related
deaths outside Dublin. These data follow
trends in people seeking treatment for
problem opiate use. 
■ More men than women have died of direct
drug-related incidents.
■ Entry to or exit from prison is a risk period for
drug-related deaths.
■ Opiate-related deaths account for the largest
proportion of direct drug-related deaths.
■ Polysubstance use is associated with deaths
among drug users.
■ Injecting drug use is associated with infection
and subsequent mortality.
Mr Niall Cullen, assistant principal officer at the
Department of Justice, Equality and Law Reform,
thanked the Coroner Service for its positive
involvement in relation to data collection for the
Index. He acknowledged the pain and grief
involved for bereaved families. He envisaged that
the Index would provide more precise information
and help in developing responses to the problem.
He thanked the minister for launching the Index,
the Family Support Network for highlighting the
problem and contributing to the solution, the
Department of Health and Children for their
successful work in partnership with his own
department in establishing the Index, and both Dr
Joe Barry and Dr Jean Long for the key roles they
played. He concluded by stating that the Health
Research Board is the most appropriate institution
to host this Index.
Mr David Moloney concluded by thanking the
audience in attendance and reiterating the
acknowledgement and thanks to all those involved
in what may become a leading example in Europe
of how drug-related deaths are recorded and
analysed. (Ena Lynn and Jean Long)
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Call for renewed commitment to 
local structures
A major conference organised by the Local Drugs
Task Force Chairs and Co-ordinators Network has
highlighted the continuing difficulties faced by
local groups in dealing with the drugs problem in
their own communities and the need for greater
support from Government if this effort is to be
sustained. The conference was held in the Royal
Hospital Kilmainham on 3 October 2005 and was
attended by over 400 delegates, including
members of local drugs task forces (LDTFs), the
voluntary and community sector and others active
in the area.
An Taoiseach Mr Ahern TD, who opened the
conference, and a number of senior civil servants
heard several speakers express concern that
support from state agencies for local efforts to deal
with the drug problem had waned in recent years.
Mr David Connolly, Chair of the LDTF Network,
told the conference that ‘it is vital that the
Government formally and publicly re-state their
support for the lead role of the local and regional
drug task forces, and in the context of the National
Drugs Strategy commit the relevant departments
and agencies to maintain and increase their
involvement in these local structures and their
response to the drug crisis’.
A number of people from the voluntary sector who
have been active in the drugs area for several years
addressed the conference. Ms Anna Quigley, 
co-ordinator of CityWide Drugs Crisis Campaign,
said that, while community-led partnerships
dominated in the early years of the LDTFs,
increasing bureaucracy in recent years has caused
decision making to move away from local areas.
She said that the level of involvement from
statutory agencies varied considerably and was
often determined by the commitment of the
individual statutory representatives on the LDTFs.
She also said that it was vital that statutory
representatives be given the support and direction
to make a real contribution to this work. Mr Hugh
Greaves of Ballymun LDTF referred to highly
favourable evaluations and reviews of the LDTFs
and the recent tributes paid to them in the mid-
term review of the National Drugs Strategy. He
said that the LDTFs had made considerable
progress over the last eight years but there was a
need to strengthen the partnership approach
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which had led to this progress. Mr Tony
Geoghegan, director of Merchants Quay Ireland,
Ms Emily Reaper of UISCE, the drugs users’ forum,
and Sadie Grace of the Family Support Network
also addressed the conference. Mr Dermot
McCarthy, Secretary General at the Department of
the Taoiseach, also emphasised the need to
support statutory representatives on the LDTFs,
some of whom may feel removed from the centre
of policy making. Mainstreaming of drugs projects
was a very necessary part of developing
accountability, equity, transparency and efficiency.
He assured delegates that the Government was not
complacent on the drugs issue.
The second part of the conference comprised a
number of parallel workshops, each dealing with
an aspect of the partnership model on which the
work of the LDTFs is based. Among the proposals
agreed by the various workshops was the
establishment of the Family Support Network as an
autonomous organisation with a representative on
the National Drugs Strategy Team (NDST). The
need for LDTFs to draw up multi-annual plans,
supported by ring-fenced budgets, was identified
during the Operational Guidelines workshop. This
workshop also proposed that the LDTFs be
renamed Local Drugs Strategy Teams, and pointed
to the need for clarification from the NDST on
what mainstreaming of LDTF projects means.
Another workshop emphasised the importance of
an early decision on benchmarking of salaries of
LDTF staff. It also noted the need to employ more
administrative staff and to protect this recruitment
from staff ceilings as the HSE is now responsible for
funding most projects. The Policing workshop
proposed that the NDST should direct all LDTFs to
develop community policing fora in their areas,
with the focus on drugs and drug crime. This
workshop emphasised the importance of Garda
acknowledgement of the role of community
policing and the need for specialised training
which would allow community gardaí to work
effectively in LDTF areas. The workshop on the
Mid-term Review of the National Drugs Strategy
called for a more co-ordinated approach to
developing drug and alcohol policy.
The proposals emerging from the workshops were
reported back to the conference. Minister of State
with responsibility for the drugs strategy, Mr Noel
Ahern TD, responded to these proposals and
assured the delegates that the Government was
fully committed to achieving the objectives
outlined in the strategy.
In a closing statement, the conference called on
the Government and state agencies to re-engage
fully with the LDTFs in their efforts to respond to
the drugs crisis. Priority must be given to
implementing the specific dedicated actions
outlined in the National Drugs Strategy mid-term
review. It is essential that the Government
responds urgently to the emerging drugs problems
throughout the country and that additional LDTFs
are established. The conference also proposed that
each LDTF produce a new strategic action plan for
the remaining period of the National Drugs
Strategy. This is necessary to maintain a strategic
and coordinated response at a local community
level. (Brian Galvin)
LDTF Conference (continued)
An Taoiseach, Mr Bertie Ahern TD, and Mr David
Connolly, chair of the Local Drugs Task Force
Network, at the conference (Photo: Unique
Perspectives)
Ms Sadie Grace (Family Support Network), Ms Emily Reaper (UISCE), An Taoiseach Mr Bertie Ahern TD
and Mr Hugh Greaves (Ballymun Local Drugs Task Force) at the conference (Photo: Unique Perspectives)
The conference
called on the
Government and
state agencies to
re-engage fully
with the LDTFs in
their efforts to
respond to the
drugs crisis.
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Welcome to the thirteenth EDDRA (Exchange on
Drug Demand Reduction Action) column. The aim
of this column is to inform people about the online
EDDRA database, which exists to provide
information on good practice interventions to
policy makers and those working in the drugs area
across Europe, and to promote the role of
evaluation in reducing demand for drugs. The
database is co-ordinated by the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). 
As part of the continuous drive to improve the
quality of interventions included on the EDDRA
database, the EMCDDA is currently developing the
Prevention and Evaluation Resource Kit (PERK). This
resource will be available on the website of the
EMCDDA (www.emcdda.eu.int) and will include
information on evidence-based prevention
principles, the essential rules of project planning
and evaluation tips. Additionally, it will provide
related documentation and references for
download to facilitate individuals who might
experience difficulty accessing the scientific
prevention literature. PERK promotes the notion
that the planning of prevention programmes and
their evaluation are intrinsically interlinked. A well-
planned programme must from the very beginning
take into account the means by which it can 
be evaluated.
If you are planning to design an intervention in the
field of drug prevention, PERK will facilitate you by
taking you on a step-by-step guided tour through
the development of an intervention and through
the available knowledge base in prevention. This
will enable you to compile or revise ideas and
suggestions on how to plan and design your
intervention, including its evaluation. By using
PERK you will come to see that not everything in
the field of drug prevention is a matter of opinion.
There is a strong evidence base and a sufficiently
robust theoretical base for practitioners to
recognise what should and should not be included
under the heading of drug prevention. 
In order to promote the role of PERK in improving
the quality of prevention interventions for the
EDDRA database, the Drug Misuse Research
Division of the Health Research Board is planning
to hold a number of workshops with individuals
and groups that are currently planning or revising
an intervention in this field. The workshops will
include an introduction to both the EDDRA
database and the PERK resource online,
highlighting the most useful navigational routes.
Using the PERK resource, the workshops will bring
you through the key steps in the development of
an intervention and will introduce you to the
available knowledge base on the key components
of effective drug prevention. The workshops will
include a large participatory element where you
will have the opportunity to compare your ideas
on designing prevention programmes with the
existing knowledge base in the field of drug
prevention. It is envisaged that the workshops 
will be run during the first quarter of 2006 at 
HRB offices, with the exact dates to be decided.
(Martin Keane) 
If you are currently planning or revising an
intervention and wish to be included on
the list of participants for the workshops,
you may contact:
The EDDRA Manager Martin Keane, 
at the Drug Misuse Research Division,
Health Research Board, Holbrook House,
Holles Street, Dublin 2. 
Tel: 01 6761176 ext 169,  
or Email: mkeane@hrb.ie
The EDDRA column 
On 9 August 2005, the minister of state at the
Department of Health and Children introduced a
new Statutory Instrument known as the ‘Medical
Products (Prescription and Control of Supply)
(Amendment) Regulations 2005’.1 These
regulations permit the supply of a number of
medicinal products (including naloxone, for the
management of respiratory depression secondary
to a known or suspected narcotic overdose) to 
pre-hospital emergency care providers. This
medication can be administered by advanced
paramedics in accordance with clinical procedure
guidelines or following a medical practitioner’s
instruction. In addition, emergency technicians
may administer naloxone in accordance with a
medical practitioner’s instruction. This will improve
the speed of response to narcotic overdoses and
may prevent deaths due to overdose of opiate-type
drugs.  (Jean Long)
1. Statutory Instrument No. 510 of 2005.
Medicinal Products (Prescription and Control of
Supply) (Amendment) Regulations 2005.
Dublin: Stationery Office.
Emergency services can now administer
naloxone
drugnet
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EMCDDA Annual Report 2005
The latest facts and
figures on drug use
across Europe, and by
country, are contained
in the 10th annual
report of the
European Monitoring
Centre for Drugs and
Drug Addiction
(EMCDDA) launched
on 24 November
2005. The report
points to an increase
in cocaine use and in
drug law offences
across Europe, and highlights the problem of drug
injecting in prisons throughout Europe. The report
includes information on the situation in Ireland
provided by the Drug Misuse Research Division of
the Health Research Board, which is the Irish
national focal point for the EMCDDA. 
Cocaine
Increases in cocaine use across Europe are fuelling
concern that cocaine is becoming the stimulant
drug of choice for many young Europeans. Surveys
in EU countries show that between 1% and 12%
of young adults (15–34 years) report using cocaine
at some point in their lives. In Ireland, figures from
the 2002/2003 National Advisory Committee on
Drugs general population survey indicate that
nearly 5% of young adults have tried cocaine at
least once, putting Ireland in mid EU range.
Crime and prison 
Most EU countries report an increase in drug law
offences. Possession (for personal use) accounts for
the largest proportion of such offences. In Ireland,
there has been an upward trend in the number of
prosecutions for drug supply since 2001, in
contrast to simple possession offences, which have
decreased by 31.5%. The report notes the
‘considerable increases’ in the availability of
substitution treatment in prisons in a number of
countries, including France and Ireland. Opiate
substitution treatment has been available in Dublin
prisons since 2001. The report also highlights the
problem of drug injecting in prisons throughout
Europe. It notes the ‘broad political consensus’ to
divert drug-using offenders from imprisonment to
treatment and looks at how some initiatives have
contributed to a decline in drug-related anti-social
behaviour. 
Treated problem drug use
The number of treated cases reported to the
National Drug Treatment Reporting System
(NDTRS) has increased steadily, from 6,048 in
1998 to 9,084 in 2003. The total number of drug
treatment services available in Ireland increased
between 1998 and 2003. The largest increase was
in outpatient treatment services and general
practitioner services. Up to 2004, less than 15% of
the 293 general practitioners prescribing
methadone participated in the NDTRS, therefore
the total numbers reported to the NDTRS are
underestimated by at least 2,000 cases. According
to the EMCDDA, the total number of clients in
substitution treatment in Europe is now over half a
million. Methadone is Europe’s most commonly
prescribed drug for the treatment of opiate
dependence, with around 80% of those in
substitution therapy receiving a methadone
prescription. 
Drug-related infectious diseases and 
drug-related deaths
In contrast to other countries in Western Europe,
the number of HIV cases among injecting drug
users in Ireland increased between 1999 and 2000,
and again between 2002 and 2004. In 2004, there
were 365 newly diagnosed HIV cases reported to
the Health Protection Surveillance Centre, of
which, 71 (20%) were infected through injecting
drug use. In Ireland, hepatitis C is endemic among
injecting drug users. Two recent studies estimated
the prevalence of blood-borne viruses among
treated opiate users in two areas of Dublin.
Between 66% and 72% of drug users tested
positive for hepatitis C, 17% for hepatitis B core
antigen, and 11% to 12% for HIV. According to
the EMCDDA, overdose is still the main cause of
death among opiate users. 
New developments in prevention
According to the EMCDDA, Ireland is the only
country in Europe to have developed an ‘intensive’
educational welfare service to work with schools
and families in disadvantaged areas to ensure that
young people attend school regularly. This is the
National Educational Welfare Board, which has
been given a key role in the National Drugs
Strategy of ensuring school attendance in local
drugs task force areas. Ireland and the UK, and to
a lesser extent the Netherlands and Portugal, lead
the field in targeting selective prevention measures
at high-risk neighbourhoods. The Young People’s
Facilities and Services Fund (YPFSF) is targeted at
the fourteen local drugs task forces and four
disadvantaged urban areas in Ireland.
Ireland was one of a few countries to report
activity in the area of drug-related social
reintegration measures, such as the provision of
housing, education, vocational training and
support for current and former drug users in
accessing the labour market. 
The report notes that it is becoming apparent
across the EU that ‘structured’ drugs strategies (i.e.
those specifying objectives, deliverables,
Annual European report on drugs
problem published
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timeframes, and responsibilities) are effective in
allowing decision makers to evaluate progress in
terms of what is working, what is not working and
what can be changed to improve performance.
The results of the Mid-Term Review of the National
Drugs Strategy, published by the Irish government
in June of this year, strongly confirm the
EMCDDA’s findings regarding the benefits of a
structured strategy. (Drug Misuse Research Division)
For a copy of the EMCDDA Annual Report 2005 and
related press material, log on to the EMCDDA
website at www.emcdda.eu.int 
The European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA) is
the central reference point for drug
information in the EU. Its role is to provide
the EU and its Member States with
objective, reliable and comparable
information on drugs and drug addiction.
The main information sources for the
EMCDDA are national focal points set up
in each EU Member State and in Norway.
European report on drugs (continued)
Treatment of under-18s presenting to
addiction services
Action 49 of the National Drugs Strategy
2001–2008 identifies the need to develop a
protocol for treating under-18-year-olds presenting
with serious drug problems.1 The report of a
working group established in October 2001 to
review this issue was published in September
2005.2
The working group reviewed the extent of the
problem and noted that ‘attendances by children
account for a substantial proportion of the
workload of the addiction services in Ireland’. 
The group considered the legal and ethical issues
surrounding the treatment of persons under 18
years old presenting with serious drug misuse
problems. The Health Act 20043 established the
Health Service Executive which now has
responsibility for discharging statutory obligations
under the Child Care Act 1991. The group
acknowledged the difficulties experienced by
service providers, particularly in relation to consent
and family involvement. They noted that the
current legislation allowed persons aged 16 to 17
years to consent on their own behalf to certain
treatments. However, there appeared to be some
doubt as to whether the courts would accept that
such consent applied to drug treatment. In this
context, it was felt that the concept of Gillick
competence, whereby professionals could assess
whether a young person was competent to give
informed consent, could play an important role.
The Health Service Executive can provide consent
on behalf of children who are the subject of a care
order or an interim emergency care order,
although it is considered good practice to consult
the parents in such cases. The group
recommended that, where possible, the family be
involved in treatment as this leads to better
outcomes. It was stated that substitution treatment
should not be initiated outside a specialist context. 
The working group believed that the four-tiered
model developed by the Health Advisory Service in
the UK, adapted as necessary to an Irish context,
would best deliver effective services to young
people presenting with problem drug use. This
approach would ensure that the services provided
would be based on the specific needs and rights of
the child and his or her family; would provide a full
range of drug-related education, prevention and
treatment interventions; and would be competent
to deal with the complex ethical and legal issues
surrounding such interventions. 
The four tiers of this model of service delivery are: 
Tier 1 Generic services provided by teachers, social
services, gardaí, general practitioners,
community and family groups for those at
risk of drug use. Generic services would
include advice and referral and would be
suitable for those considering or commencing
experimentation with drugs or alcohol. 
Tier 2 Services with specialist expertise in either
adolescent mental health or addiction, such
as juvenile liaison officers, local drugs task
forces, home-school liaison, Youthreach,
general practitioners specialising in
addiction and drug treatment centres. The
types of service delivered at this level would
include drug-related prevention, brief
intervention, counselling and harm
reduction, and would be suitable for those
encountering problems as a result of drug
or alcohol use. 
Tier 3 Services with specialist expertise in both
adolescent mental health and addiction.
These services would have the capacity to
deliver child-centred comprehensive
treatments through a multi-disciplinary team.
This team would provide medical treatment
for addiction, psychiatric treatment, child
protection, outreach, psychological
assessment and interventions, and family
therapy. These types of service would be
suitable for those encountering substantial
problems as a result of drug or alcohol use. 
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Treatment of under-18s (continued)
Tier 4 Services with specialist expertise in both
adolescent mental health or addiction and
the capacity to deliver a brief, but very
intensive, intervention through an inpatient
or day hospital. These types of service
would be suitable for those encountering
severe problems as a result of drugs or
alcohol dependence.
The working group agreed that the services would
be adolescent-specific, local and accessible, and
have a combination of disciplines on site. The
services would offer assessment, treatment and
aftercare. In addition to the extra resources
required to address the needs of these young
people, it was suggested that greater co-ordination
could maximise the impact of existing services.
(Jean Long) 
In outlining the Health Estimate for 2006,
the Tánaiste announced that drugs and
HIV services will receive additional funding
of €3 million, including provisions for the
establishment of Tier 3 teams relating to
the Under-18s Report.
Addiction Research Centre Annual
Conference
‘School and family-based programmes for
preventing substance misuse’ was the theme of the
fifth annual Addiction Research Centre conference,
held in Trinity College Dublin in September. A
panel of international and national speakers
addressed aspects of the topic in three sessions.
1. Being realistic about school programmes
Primary prevention (stopping young people from
ever using drugs or getting them to stop using) has
been the main approach to school-based drug
education, and to date it has proved to be ineffective
in preventing drug use among young people. This
was the view of keynote speaker Julian Cohen, an
independent researcher and consultant in drug
education in the UK, who argued that drug
prevention programmes based on the primary
prevention approach rely on false assumptions about
young people’s drug use and are more in the realm
of propaganda, than being based on research
evidence and what happens in the real world. Cohen
advocated a harm-reduction approach, which would
take full account of research evaluations and the
reality of young people’s drug use and would be
based on sound educational principles. Such an
approach would focus on young people’s health,
safety and well-being, rather than on whether or not
they use drugs. Cohen outlined the possible content
of such programmes, together with good-practice
guidelines for implementing them.
In response, Bernie McConnell of Community
Awareness of Drugs argued that it is unhelpful to
polarise the debate about drug prevention, as Cohen
had done, and that it is more useful to recognise the
complexity of good prevention and remain open to
new ways and ideas about overcoming the
complexity, drawing on both primary prevention
and harm-reduction approaches as appropriate. Dr
Mark Morgan of St Patrick’s College, Drumcondra,
emphasised the need to consider what expectations
we have of any school intervention; to consider the
evidence regarding implementation, and the extent
to which failures are due to non-implementation;
and to distinguish between programmes that are
relatively ‘better’ than others.
2. Prevention with high-risk families
Dr Karol Kumpfer, Professor of Health Promotion
and Education at the University of Utah, USA, gave
a paper on the Strengthening Families Program
(SFP), designed to prevent substance abuse. The
programme was based on research on over 10,000
young people, which suggested that the most
important protective mechanism against drug abuse
is the family, and that the most important protective
factors are parent/child attachment, parental
supervision and effective family communication and
expectations about the use of drugs and alcohol. Dr
Kumpfer described other research which revealed
that children of substance abusers can learn to be
resilient and have happy productive lives. In
outlining the design, content, implementation and
outcomes of the SFP, Dr Kumpfer demonstrated
how it was based on this research and focused on
reducing family risk factors by increasing family
protective and resilience factors. 
The SFP has been replicated in randomised control
trials by a number of independent researchers
other than the programme developer, Dr Kumpfer,
with large positive changes being demonstrated in
parent and child behaviour even in 10-year
longitudinal studies. Dr Kumpfer reported that the
Dr Kumpfer
described other
research which
revealed that
children of
substance
abusers can learn
to be resilient
and have happy
productive lives.
1. Department of Tourism Sport and Recreation (2001). Building on experience: National Drugs Strategy
2001–2008. Dublin: Stationery Office.
2. Working Group on treatment of under 18 year olds (2005). Report of the working group on
treatment of under 18 year olds presenting to treatment services with serious drug problems. Dublin:
Department of Health and Children.
3. Health Act 2004. No. 42 of 2004. Dublin: Stationery Office.
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SFP is listed as an evidence-based substance abuse
prevention programme by US government
research agencies and also by the WHO
International Cochrane Collaboration Reviews. 
It has age adaptations for 3–17-year-olds and is
being implemented in six countries, with about
1,000 group leaders being trained each year.
In response, Mary Cullen of Mounttown
Neighbourhood Youth Project in Dun Laoghaire
considered the practical application of family
support programmes in the context of social and
economic disadvantage. Barry Cullen of the
Addiction Research Centre welcomed the
development of programmes such as the SFP and
argued that, in developing this policy further, policy
makers and health service managers would do well
to test, evaluate and assess the application of family
intervention programmes.
3. Drugs, alcohol and the ‘whole school’ approach 
Ruby Morrow of the Church of Ireland College of
Education suggested that schools should be just one
of the groups and agencies involved in seeking to
prevent drug use among young people. Attitudes to
and use of drugs among young people reflect the
influence not only of the formal education system
but also of the family, local community, and the
wider culture and media. Morrow outlined a ’whole
school’ approach that sees schools, together with
family, peers and community, helping children and
young people develop the personal strengths and
skills to make informed decisions and deal with
challenges as they arise. The approach includes the
following key elements:
■ a health-promoting school 
■ delivery of the Social, Personal and Health
Education (SPHE) programme
■ early identification of the vulnerable and of
those experiencing difficulties 
■ referral to appropriate outside agencies (as
necessary) and in-house school support.
Sinéad O’Mahoney Carey, Drug Education Officer
with the HSE South Eastern Area, gave a regional,
as opposed to a national, perspective on the
‘whole school’ approach. She described the holistic
implementation process involved in developing
secondary school substance-use policies within the
South Eastern Area. The speaker identified the key
issues that arose in the process whereby drug
education officers worked in partnership with
schools and health promotion personnel in
implementing the policies. (Brigid Pike)
Merchants Quay Ireland (MQI) launched its Annual
Review 2004 on 16 September 2005. According to
the report, the services provide creative and
innovative responses to drug use and homelessness
in Ireland. The organisation estimated that there
are 2,009 homeless drug users in Ireland. 
A comprehensive set of drug services is provided
to drug users through MQI, ranging from needle
exchange to reintegration programmes. The
numbers of drug users who received services
through these programmes in 2004 are presented
in the table below. 
Addiction Research Centre Annual Conference (continued)
Merchants Quay Ireland launches its
annual review for 2004
Name of service Type of intervention Number of participants Outcomes
Needle Exchange of injecting equipment 3,300 (including  Not applicable
Exchange–Health 450 new cases)
Promotion Unit Safer injection training 256 workshops 
Safe sex advice Not available 
Health and social care services
Outreach service Not available
Methadone Prescribing, counselling and 30 Not provided
programme health-care support
High Park  Residential detoxification 13 10 successful  
Residential detoxifications
Programme Medication-free therapy 58 Not provided
St Francis Farm Therapeutic and personal 22 (18 discharged) 12 completed 3
development programme months or more
FAS Community 120 52 gained 
Employment Services employment
MQI completed two important research projects ‘Drug use among the homeless population in Ireland’
and ‘Drug use among new communities in Ireland’ in 2004; the results of these projects were published
in 2005 and were covered in issue 14 of Drugnet Ireland. (Jean Long)
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Reach Out: National strategy for action on
suicide prevention, 2005–2014
The national
strategy for action
on suicide
prevention, titled
Reach Out, was
published in
September 2005.1
The definition of
suicide used by the
authors was ‘suicide
is a conscious or
deliberate act that
ends one’s life when
an individual is
attempting to solve a problem that is perceived as
unsolvable by any other means’. 
The Central Statistics Office (CSO) compiles
mortality data on suicide in Ireland. This is done
using the findings of coroners’ inquests and data
provided in Form 104 completed by the Garda
Síochána. The CSO reported that there was an
average of 494 deaths as a result of suicide each
year between 2000 and 2002. The annual rate for
men rose steadily, from 10 per 100,000 in 1990 to
24 per 100,000 in 1998: the rate dropped to 19
in 2002. The annual rate for women remained
stable at around 5 per 100,000 between 1990 and
2002; however, according to the information
provided, suicide rates increased among women
aged 15 to 24 years. Taking the number of deaths
for which the underlying cause is undetermined
and expressing it in relation to the number of
deaths for which the underlying cause is suicide, it
is calculated that, because of doubtful cases, there
is on average a 5% possible under-estimate of
annual suicide numbers; the under-estimate rose
to 18% in 2002. Given that the under-estimate
varies, it is difficult to calculate exact suicide
figures over time. Suicide is more common among
men than women. The majority of suicides among
males occur in those aged between 20 and 34
years, while the majority among women occur in
those aged between 45 and 59 years. 
The data on deliberate self-harm collected at
accident and emergency units throughout Ireland
indicate that such harm was more common
among women than men in 2003.2 There were
over 11,000 cases of deliberate self-harm in 2003;
the rate for men was 177 per 100,000 and for
women was 241 per 100,000. In 2003, 21% of
cases were repeat acts. Drug overdose was a more
commonly used method of self-harm by women
(80%) than by men (64%), while self-cutting was
a more commonly used method by men (23%)
than by women (14%). Alcohol was involved in
47% of male episodes and in 39% of female
episodes. 
Reach Out makes the point that social changes
have impacted on the nature and extent of
suicidal behaviour in Ireland. Suicide rates doubled
during the 1980s and 1990s. This was a time
when society experienced considerable transition
from an agricultural rural economy to an urban
service-orientated one. The church and rural
norms were challenged. There have been
considerable changes for young adults and older
people. Young men in rural areas can no longer
assume that they have a livelihood from farming,
fathers are isolated with the increasing number of
single parent families, teenage girls struggle with
media-induced expectations about their physical
appearance, and older people no longer have the
support of an extended family network. Increasing
socio-economic inequalities and social exclusion
affecting a variety of groups residing in Ireland
also increase suicide rates. It is clear that this is not
just a health problem, but a social one. 
This strategy document builds on work by a
number of groups since 1995. The four levels of
action identified in the strategy were developed
through a series of consultations throughout
Ireland. The levels of action are: general
population approach, targeted approach,
responding to suicide, and information and
research. 
The general population approach will promote
positive mental health and bring about a positive
attitude towards mental health, problem solving
and coping in the general population through 11
major agents who will implement 42 actions. 
The targeted approach will reduce the risk of
suicidal behaviour among high-risk groups and
vulnerable people. These include those who
commit deliberate self-harm, those at risk of or
abusing alcohol and drugs, marginalised groups,
prisoners, unemployed people, people who have
experienced physical or sexual abuse, young men
and older people. The Garda Síochána will be
supported in carrying out their duties in relation to
suicidal behaviour. There will be a number of
actions to limit access to the means of self-harm. 
The response to suicide will minimise distress felt
by families, friends and the community following
death, and ensure that individuals are not isolated
or left vulnerable, so as to reduce the risk of
related suicidal behaviour. 
Information and research will be used to inform
service development and provide information on
where and how to get help. It is proposed to link
and exchange data between a number of health
information systems, including the National
Parasuicide Registry, the Hospital In-Patient
Enquiry scheme, the National Psychiatric Inpatient
Reporting System and the National Drug
Treatment Reporting System. It is not clear how
the latter will be able to assist in providing
Suicide rates
doubled during
the 1980s and
1990s.
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information relating to the circumstances of suicide
deaths since it does not collect data on clients
exiting treatment. The HRB maintains the National
Drug-Related Deaths Index, which may be a more
useful source of data. (Jean Long)
1. Health Service Executive, National Suicide
Review Group and Department of Health and
Children (2005) Reach Out: National strategy for
action on suicide prevention, 2005–2014. Dublin:
Health Service Executive.
2. National Parasuicide Registry Ireland (2004)
Annual Report 2003. Cork: National Suicide
Research Foundation.
In outlining the Health Estimate for 2006,
the Tánaiste announced that €1.2 million
will be allocated to support the
implementation of Reach Out: National
strategy for action on suicide prevention. 
Reach Out (continued)
Update on blood-borne viruses
A number of studies published in 2004 and 2005
update or advance our knowledge of hepatitis C
among drug users in Ireland.
Grogan et al.1 assessed the uptake of screening for
and estimated the prevalence of hepatitis C in 358
heroin users attending 21 drug treatment clinics in
the HSE South Western Area up to December
2001. A one-in-four systematic sample of clients
prescribed methadone in the 21 drug treatment
clinics in the area in December 2001 was selected
from the Central Treatment List. Data collected
from the clinical records showed that 88% of the
sample had had a test for hepatitis C, of whom
66% had tested positive. These results are in line
with those from other studies in a similar setting.
The authors point out that the results were
ascertained from clinical records and pertain only
to those documented in the clinical records. The
tests recorded had been administered over 
an extended time period and those testing
negative at their first test may have subsequently
sero-converted and not have had a repeat test. 
In addition, injector status was not ascertained and
the authors acknowledge that the proportion of
injectors testing positive for each virus would be
higher. 
A study by O’Sullivan,2 using a cross-sectional
survey method, assessed the prevalence of 
blood-borne viruses among 90 injecting drug 
users attending an opiate-substitution programme
at the Drug Treatment Centre Board. The sample
size was estimated using a wide 10% level of
precision and a 95% level of confidence. The
author obtained adequate blood samples from 
65 of the 90 clients interviewed. In total, 72%
tested positive for hepatitis C. 
In another published study, Keating and
colleagues3 estimated the proportion of hepatitis C
positive individuals with each genotype in an
intravenous drug-using cohort, and then estimated
the proportion that spontaneously cleared the
hepatitis C virus. The study followed the progress
of 496 hepatitis C antibody-positive individuals
attending five drug treatment centres in Dublin. 
Of the 299 PCR-positive samples that had their
genotype determined, genotypes 1 and 3 were the
most common (see table). The PCR test detects
whether the virus is still in the blood and will show
if a person has an ongoing infection. 
Number of PCR positive samples of selected
hepatitis C antibody positive individuals
attending five drug treatment centres in Dublin,
by genotype
Genotype Number (%) 
Total =299
1 146 (48.8%)
2 6 (2.0%)
3 145 (48.5%)
4 2 (0.7%)
5 0 (0.0%)
6 0 (0.0%)
Of the 496 hepatitis C antibody-positive
participants in the sample, 191 (38.5%) were
shown to be HCV RNA negative when re-tested,
indicating that they had spontaneously cleared the
virus. A higher proportion of women (47.4%) than
men (34.5%) cleared the virus spontaneously. A
higher proportion of those with a history of
jaundice (12.0%) than those who reported no
history of jaundice (7.9%) cleared the virus. 
Smyth et al.4 examined the contribution of unsafe
injecting practices and the social context of
injecting in Dublin to infection with hepatitis C. Of
the 242 participants who completed the
questionnaire, 159 were tested for hepatitis C; of
these, 61% tested positive for hepatitis C. After
controlling for other factors, the authors found
that an increased number of lifetime injecting
episodes increased the risk of hepatitis C infection.
In relation to the social context, individuals who
injected in the home of another injecting drug user
were almost five times more likely to test positive
for hepatitis C than those who injected in their
own home or elsewhere. Individuals who injected
in the company of close friends or family members
were around three times more likely to test
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drugnet
IRELAND
positive for hepatitis C than those who injected
with acquaintances. 
Cullen et al.5 examined the experiences with
respect to risk practices of heroin users attending a
general practice for investigation of and treatment
for hepatitis C. The study questionnaire had a mix
of closed and open questions. At the time of the
study, 38 former or current heroin users were
registered with the practice. Of these, 25 (66%)
agreed to be interviewed. Those interviewed were
more likely to be female and older than the other
heroin users attending the practice. At the time of
the study, 23 of the 25 participants were receiving
methadone maintenance. Twenty-two participants
said that they had tested positive for hepatitis C
and, of these, 15 had consumed alcohol in the
week prior to the study. Nine had consumed more
than the recommended amount of alcohol per
week for their gender. Of note, eight reported
neither drinking excessively nor using heroin in the
previous six months and were therefore suitable for
investigation. Only four of the eight suitable clients
were referred for further investigation and one had
commenced treatment. Those respondents who
reduced their alcohol intake did so because they
were concerned about their health, while those
who increased their alcohol intake did so to
substitute for heroin. Some respondents had a
negative perception of liver biopsy; those who had
undergone this investigation reported that the
procedure was not as difficult to tolerate as
expected. Many respondents had negative
perceptions of antiviral treatment. The experience
of treatment by medical and nursing personnel at
secondary treatment services was mixed. 
Over two-thirds of opiate users have tested positive
for hepatitis C in Dublin. The rate of spontaneous
viral clearance for this infection was higher than
previously reported. There are a number of barriers
to hepatitis C treatment for injecting drug users
which need to be addressed so as to encourage
uptake of treatment. (Jean Long)
1. Grogan L, Tiernan M, Geoghegan N, Smyth B
and Keenan E (2005) Bloodborne virus
infections among drug users in Ireland: a
retrospective cross-sectional survey of screening,
prevalence, incidence and hepatitis B
immunisation uptake. Irish Journal of Medical
Science, 174(2): 14–20.
2. O'Sullivan P (2004) A study of the prevalence of
blood-borne viral diseases in injecting drug users
receiving methadone maintenance in the National
Drug Treatment Centre at Trinity Court in Dublin.
Thesis submitted for membership of the Faculty
of Public Health Medicine, Royal College of
Physicians of Ireland.
3. Keating S, Coughlan S, Connell J, Sweeney B
and Keenan E (2005) Hepatitis C viral clearance
in an intravenous drug-using cohort in the
Dublin area. Irish Journal of Medical Science, 174
(1): 37–41. 
4. Smyth BP, Barry J, and Keenan E (2005) Irish
injecting drug users and hepatitis C: the
importance of the social context of injecting.
International Journal of Epidemiology, 34(1):
166–172.
5. Cullen W, Kelly Y, Stanley J, Langton D and Bury
G (2005) Experience of hepatitis C among
current or former heroin users attending general
practice. Irish Medical Journal, 98 (3): 73–74.
Update on blood-borne viruses (continued)
The 2003 annual report of the National Parasuicide
Registry defines parasuicide as ‘an act with 
non-fatal outcome in which an individual
deliberately initiates a non-habitual behaviour, that
without intervention from others will cause self-
harm, or deliberately ingests a substance in excess
of the prescribed or generally recognised
therapeutic dose and which is aimed at realising
changes that the person desires via actual or
expected physical consequences’.1 Internationally,
according to the report, the term parasuicide is
being superseded by the term ‘deliberate self-harm’.
Since 2001, the National Suicide Research
Foundation has collected data on deliberate 
self-harm in Ireland through its National Parasuicide
Registry. Each accident and emergency unit and
prison provides data on every episode of self-harm
that they attend. Up to 2004, there was complete
coverage in all HSE areas outside the Eastern
Region. Three hospitals in the Eastern Region did
not make returns until 2004; the rates given in the
2003 report were adjusted to take account of this.
According to the report, there were 11,200
presentations in 2003 as a result of deliberate 
self-harm, involving 8,800 individuals, whereas in
2002 there were 10,500 presentations involving
8,400 individuals. In 2003 the age-standardised
rate of self-harm was 209 per 100,000, while in
2002 the rate was 202 per 100,000; this represents
an increase of almost 4%. Every year, a number 
of individuals present more than once in the
twelve-month period; 21% of cases presented more
than once in 2003, while 19% of cases presented
more than once in 2002. The rate of deliberate self-
harm was lower among males (177 per 100,000)
than among females (241 per 100,000) in 2003,
though the difference in 2003 was smaller than the
rates in 2002, 36% versus 42% respectively. Just
under 47% of presentations were aged under 30
years. The peak age for women was 15–19 years,
while for men it was 20–24 years. 
Drug overdose was the commonest method of
self-harm, representing almost 79% of all such acts
registered in 2003. Half of all overdose acts
Deliberate self-harm in Ireland in 2003
The PCR test
detects whether
the virus is still in
the blood and will
show if a person
has an ongoing
infection. 
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involved at least 25 tablets. In general, men took
more tablets than women. For example, at least 50
tablets were taken by 21% of men compared to
15% of women. It was common for cases to take
more than one drug. The most common drugs
used in deliberate self-harm were minor
tranquillisers (41%), paracetamol (31%) and
antidepressants (24%). 
Self-cutting was the second most common method
of self-harm, representing 18% of all acts
registered in 2003. Cutting was more common in
men (23%) than in women (14%). This finding
reflects those in the United Kingdom but not
internationally. 
The report highlights the challenge the deliberate
self-harm poses for Irish health services and for
society. Deliberate self-harm is a predictor of both
non-fatal and fatal suicidal behaviour. It is a
symptom of mental health problems and distress
in our society, and a major cause of suffering for
individuals and their families. There is a need to
understand the reasons for self-harm in society and
to prevent repeat episodes among individuals. The
open discussion in general society, which
commenced in recent years, needs to continue but
it should be informed and sensitive. (Jean Long)
1. National Parasuicide Registry Ireland (2004)
Annual Report 2003. Cork: National Suicide
Research Foundation.
Deliberate self-harm in Ireland in 2003 (continued)
Drug overdose
was the
commonest
method of self-
harm,
representing
almost 79% of 
all such acts
registered in
2003.
New information on cannabis use in
Ireland
On 7 October 2005 the National Advisory
Committee on Drugs (NACD) in Ireland and the
Drugs and Alcohol Information and Research Unit
within the Department of Health, Social Services
and Public Safety in Northern Ireland published
jointly the third bulletin of results from the
2002/2003 all-Ireland general population drug
prevalence survey.1 This latest bulletin focuses on
cannabis use in the adult population (15–64 years)
and attitudes to cannabis use. Minister of State at
the Department of Community, Rural and Gaeltacht
Affairs with responsibility for drugs strategy, Mr Noel
Ahern TD, launched the findings for Ireland. This
article highlights some of those findings.
Current cannabis users (used cannabis in the last
month) are more likely to use resinous hash than
herbal cannabis (marijuana, weed, grass) and they
most commonly smoke cannabis in a joint rather
than consume it in other ways, such as using a
pipe or eating it. In total, 2.6% of those surveyed
had used cannabis in the month prior to the
survey, of whom one out of every five (22%) were
using cannabis daily or almost daily. Since the
survey was representative of the adult population,
it can be estimated from the above figures that
approximately one in every 175 adults is using
cannabis on a daily or almost daily basis.
Over a quarter (27%) of respondents who had
ever taken cannabis stated that they had used it
‘regularly’ at some stage in their lives. This
increased to almost a third (31%) for young adults
(15–34 years). Regular use was self-defined by
respondents. The average number of years
between first use of cannabis and starting regular
use of the drug was two years. This was the same
for both young adults and older adults (35–64
years). Regular users were asked if they had ever
tried to stop. Three out five (68%) had stopped,
while 12% had tried, but failed to stop. Of the
regular users who had successfully stopped using
cannabis, 20% stated that they did so because of
health concerns, while 23% stopped because they
did not enjoy the after-effects.
The vast majority (79%) of those who had used
cannabis in the last year (recent users) considered
it ‘very easy’ or ‘fairly easy’ to obtain within a 
24-hour period. This view on ease of access was
expressed by both young adults and older adults.
The house of a friend was the most common place
where cannabis could be obtained and family and
friends were the main sources of the drug.
All those surveyed who had heard of cannabis
were asked about their attitudes to cannabis use.
While most people did not wish cannabis to be
permitted for recreational use, it is of note that one
in five (21%) agreed (either fully or largely) that
people should be permitted to take cannabis for
recreational purposes, and almost one in three
(30%) did not disapprove of people smoking
cannabis occasionally. However, most of those
surveyed (96%) felt that people who smoked
cannabis regularly risked harming themselves,
physically or in other ways. The perception of risk
varied by age: younger adults perceived regular
cannabis use as less risky than did older adults.
Drug prevalence surveys of the general population
are important in that they can shed light on the
patterns of drug use, both demographically and
geographically and, if repeated, can track changes
over time. They help to increase our understanding
of drug use, and to formulate and evaluate drug
policies. They also enable informed international
comparisons, provided countries conduct surveys
in a comparable manner. 
It can be
estimated... that
approximately
one in every 
175 adults is
using cannabis 
on a daily or
almost daily
basis.
Most of those
surveyed (96%) felt
that people who
smoked cannabis
regularly risked
harming
themselves,
physically or in
other ways.
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New information on cannabis use in Ireland (continued)
The Irish drug prevalence survey followed best-
practice guidelines recommended by the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). The questionnaire, based on the
‘European Model Questionnaire’, was administered
in face-to-face interviews with respondents aged
between 15 and 64 years normally resident in
households in Ireland. Fieldwork was carried out
between October 2002 and April 2003. The final
achieved sample was 4,918, representing a
response rate of 70%. The sample was weighted
by gender, age and region to maximise its
representativeness of the general population.
(Hamish Sinclair)
1. National Advisory Committee on Drugs and Drug
and Alcohol Information and Research Unit (2005)
Drug use in Ireland and Northern Ireland. 2002/
2003 drug prevalence survey: cannabis results.
Dublin: National Advisory Committee on Drugs.
Teenage cannabis use targeted
On 17 October 2005 the Health Promotion Unit of
the Department of Health and Children launched a
new phase of the National Drugs Awareness
Campaign aimed at dispelling the myth among
teenagers that cannabis use is harmless. This new
phase targets both male and female teenagers and
comprises a radio advertisement and two posters
on the theme ‘Being a teenager is hard enough,
without being stoned too’. The radio advertisement
mimics advertisements for teen magazines to
communicate the negative impact smoking
cannabis can have on the health and well being of
young users. The posters mimic the front covers of
teen magazines to deliver the same message. The
posters appear in public places where teenagers
gather, such as bus stops near secondary schools,
shopping malls in urban areas and computer game
stores. (Hamish Sinclair)
Further information is available on the National
Drugs Awareness Campaign website at
www.drugsinfo.ie
Elisad conference
The 17th annual conference of the association of
European Library and Information Services in
Alcohol and other Drugs (Elisad) was held in Oslo
in October. Ingeborg Rossow from Sirus, the host
organisation and Reitox focal point for Norway,
described the historical development of Norway’s
alcohol policy and how current policy compared to
that of other European countries. Odd Hordvin,
also of Sirus, described the work of the focal point.
Alfred Uhl of the Boltzmann Institute for Addiction
Research in Vienna presented a paper which
questioned many of the conclusions from alcohol-
related research which currently inform policy in
this area. In particular, he argued that the link
between higher prices and reduced consumption
and a reduction in problem alcohol use had not
been clearly established. 
Barbro Andersson, ESPAD co-ordinator from CAN
in Stockholm, presented an overview of the most
recent ESPAD survey of alcohol and other drug use
among European students aged 15–16. Jessica
Hinkson, manager of information services at the
Center for College Health and Safety in Boston,
reviewed the latest literature on alcohol and other
drug abuse on US campuses and in surrounding
communities. Recent studies show that while high-
risk alcohol use is relatively unchanged and ecstasy
use is down on most US campuses, cocaine,
methamphetamine and prescription drug abuse
are on the rise. Information specialists from
DrugScope in London, from CAMH in Toronto and
from the Alcohol Research Group Library in
California also presented to the conference.
Information specialists from the National
Documentation Centre on Drug Use facilitated
workshops on open access journals and knowledge
management. (Brian Galvin)
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The CityWide Drugs Crisis Campaign,
which supports community development
approaches to dealing the drugs problem,
has launched a new website
(www.citywide.ie). The site contains
information on CityWide’s work and
includes a news and publications section.
Earlier this year CityWide celebrated its
10th anniversary. 
CityWide launches new website
Government reports progress on new
drug initiatives
In June 2002 the incoming Fianna Fáil–Progressive
Democrat government published An Agreed
Programme for Government, setting out its priorities
for 2002–2007.1 While broadly endorsing the
Supply Reduction, Prevention and Treatment pillars
of the National Drugs Strategy, the new
government also pledged to undertake five new
initiatives designed to contribute to achieving drug-
free prisons, reducing drug supply and improving
information regarding the drug situation. Progress
in relation to these pledges, as outlined in the
government’s most recent annual progress report,
published in July 2005,2 is set out below. 
We will provide for compulsory drugs testing of
prisoners where appropriate. 
In mid-2005 new Prison Rules were published,
including specific provision for mandatory drug
testing. Mandatory drug testing is one of a raft of
new measures intended to render Irish prisons
drug free, which are contained in the new Drugs
Policy and Strategy for the Irish Prison Service,
announced by Michael McDowell TD, the Minister
for Justice, Equality and Law Reform, on 21
November 2005. The drive to eliminate all drugs
and drug use in prisons is balanced in the new
strategy by a commitment to underpin and
expand existing treatment services, which involve
a combination of detoxification, methadone
maintenance and reduction programmes,
education and awareness programmes, addiction
counselling, drug therapy programmes and
psycho-social support. 
Where a person has been found to be involved
in the supply of drugs to a prisoner we will
introduce a stiffer penalty.
An amendment to the Criminal Justice Bill 2004,
introduced during the Committee stage, will create
a new offence of supplying drugs to prisoners.
We will require convicted drug dealers to
register with the Gardaí after leaving prison.
An amendment to the Criminal Justice Bill 2004,
introduced during the Committee stage, provides
for the registration of convicted drug dealers on a
drug offenders held by the Garda Síochána. The
Minister for Justice, Equality and Law Reform
recently indicated that this proposal is based on
the same principles as the sex offenders register
and will enable the movement of convicted drug
dealers to be recorded in a similar fashion,
covering change of address and movement in and
out of the State.3
We will ensure that an early warning system,
involving all key agencies, is in place to track
the potential spread of heroin into new areas. 
Recognising the time-lag limitations of many of the
traditional drug-use indicators, the National
Advisory Committee on Drugs (NACD) is pilot
testing aspects of a Drug Trend Monitoring System
(DTMS). The aspects being pilot tested include the
establishment of a Trends Monitor Network
throughout the country to provide local
knowledge on drug trends, the monitoring of
media reports on drug-related court cases and
seizures, and the running of drug-user focus
groups at local level to gain an understanding of
drug-using behaviour. The aim of the system is to
obtain information on emerging drug-use patterns
and trends on a more timely basis. This
information will be used to complement the
existing drug indicators. A report on the pilot
DTMS has been submitted to the Cabinet
Committee on Social Inclusion for consideration. 
We will continue to prioritise heroin and
cocaine for intervention, and will publish
separate national targets for supply reduction
for each major type of drug.
In reporting on this initiative, the government
indicates that it accepts the following key
performance indicator in the National Drugs
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Strategy: ‘A key indicator in the Strategy is to
increase the volume of opiates and all other drugs
seized by 25% by end of 2004 and by 50% by end
2008, using 2000 seizures as a base.’ While
representing successive aggregate targets, the
government has chosen not to specify separate
targets for each major type of drug.
The drugs issue and social inclusion
In its Agreed Programme, the newly-elected
government also initiated actions seeking to build
an inclusive society that will also impact on the
drugs issue. The promotion and piloting of local
corporate social responsibility (CSR) initiatives as
part of its agenda for community, local and rural
development, for example in areas affected by
drugs and social or rural disadvantage, was one
such action. In its recent progress report the
government indicates that CSR projects could
include provision by companies of work experience
for the long-term unemployed, sponsorship of
third-level education for disadvantaged students,
mentoring of business start-ups by unemployed
people, and financial support of homework clubs
and breakfast clubs in disadvantaged schools. 
Under the heading ‘Regenerating urban
communities’, the incoming government also
pledged to continue the Young People’s Facilities
and Services Fund (YPFSF) and complete a
comprehensive survey of the availability of
recreation facilities in disadvantaged areas. In its
recent progress report, the government reports
that, to date, total allocation under the Fund is
almost €85 million, and that a round of capital
funding, also announced in July 2005, will allow
for over 40 youth and community facilities in 10
local drugs task force areas to be upgraded and
refurbished. (Brigid Pike)
1. Fianna Fáil and the Progressive Democrats
(2002) An Agreed Programme for Government
between Fianna Fáil and the Progressive
Democrats. Dublin: Fianna Fáil and the
Progressive Democrats.
2. Fianna Fáil and the Progressive Democrats
(2005) Government progress report on the
implementation of An Agreed Programme for
Government between Fianna Fáil and the
Progressive Democrats. Dublin: Fianna Fáil and
the Progressive Democrats.
3. McDowell, Michael (2005, 7 September)
‘Presentation on the Criminal Justice Bill 2004 to
the Joint Committee on Justice, Equality,
Defence and Women’s Rights’. Official Report
Parliamentary Committees (29th Dáil) Vol. 95.
Government reports progress on new drug initiatives (continued)
Legal briefing
This legal briefing reviews some of the significant
drug-related legislative initiatives introduced
during 2005.
The Proceeds of Crime (Amendment) Act 2005
makes further provision in relation to the recovery
and disposal of proceeds of crime and, for that
purpose, amends the Proceeds of Crime Act 1996,
the Criminal Assets Bureau Act 1996, the Criminal
Justice Act 1994 and the Prevention of Corruption
(Amendment) Act 2001. While the new Act does
not make specific reference to drugs, proceeds of
crime legislation has been directed against those
involved in organised crime involving drug
trafficking. The Act also allows proof of criminality to
include criminality outside the State.
Section 28 of the Maritime Safety Act 2005
introduces prohibitions on the operation of vessels
in Irish waters while under the influence of alcohol
or drugs to such an extent as to be incapable of
properly controlling or operating the vessel. Section
29 entitles the person in command of a vessel to
refuse permission to board to a person who is under
the influence of alcohol or drugs to such an extent
that they misconduct themselves or cause offence or
annoyance to persons on the vessel. Section 31
introduces controls and penalties in relation to the
consumption of alcohol or drugs on board vessels. 
Section 13 of the Safety, Health and Welfare at
Work Act 2005 provides for drug testing in the
workplace. The legislation obliges the employee to
ensure that he or she is not under the influence of
an intoxicant to the extent that he or she is in such
a state as to endanger his or her own safety, health
or welfare at work or that of any other person.
Also, if reasonably required by his or her employer,
the employee must submit to any appropriate,
reasonable and proportionate tests, by or under
the supervision of a registered medical practitioner
who is a competent person, as may be prescribed.
An employer may require an employee to undergo
an assessment by a registered medical practitioner,
nominated by the employer, of his or her fitness to
perform work activities. Regulations have not yet
been finalised. The National Advisory Committee
on Drugs has commissioned research to assist in
the preparation of the necessary regulations. This
research is to consider such issues as: 
■ information on drug impairment in the
workplace
■ right to privacy on health issues in the workplace
■ information on substance use in the workplace
■ literature search on drug testing issues in 
the workplace.
The Garda Síochána Act 2005 was passed into law
in July 2005. In March 2005, the Joint Oireachtas
Committee on Justice, Equality, Defence and
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Women’s Rights conducted a review of community
policing in Ireland1 in light of proposals contained
in Chapter 4 of the Garda Síochána Bill 2004 to
establish new local policing structures. Many of the
recommendations of the Joint Committee have
been incorporated into the Act.
An important amendment to the Garda Bill has
been the inclusion of the Minister of State at the
Department of Community, Rural and Gaeltacht
Affairs with responsibility for national drugs strategy
in the preparation of guidelines concerning the
establishment and maintenance of joint policing
committees (JPCs) by local authorities and the
Garda Commissioner. The Act also provides for the
inclusion on the JPCs of ‘persons representing local
community interests’. Another important tier in the
new local policing structures is the establishment of
local policing fora. The Act provides for the
establishment of such fora by JPCs in consultation
with the local Garda superintendent ‘as the
committee considers necessary’. The steering group
which oversaw the mid-term review of the National
Drugs Strategy highlighted concerns raised during
its consultation process about the pace at which
community policing fora were developing in drugs
task force areas. In light of these concerns, and of
developments with regard to the Garda Síochána
Act 2005, a new action has been incorporated into
the Strategy: ‘Taking into account the provisions of
the Garda Síochána Bill 2004 (now enacted as of
June 2005), Community Policing Fora should be
extended to all Local Drugs Task Force areas and to
other areas experiencing problems of drug misuse.’
A committee is currently preparing guidelines for
the establishment and maintenance of the JPCs.
The Irish Medicines Board (Miscellaneous
Provisions) Bill 2005 provides for a number of
amendments to the Misuse of Drugs Act 1977,
including:
■ provisions to extend the powers available to
the Minister to give a direction, following a
conviction for an offence under the Misuse of
Drugs Acts or the Customs Acts, prohibiting
bodies corporate involved in the practice of
community pharmacy, and their officials,
from having such controlled drugs as may be
specified
■ provisions to enable the Irish Medicines Board
to issue licences and permits in respect of
controlled drugs for various purposes
■ provisions to limit the prohibition of the
cultivation of poppies to poppies that are
cultivated for the production of opium.
A number of amendments to the Criminal Justice
Bill 2004 are being proposed by the Minister for
Justice, Equality and Law Reform. The Bill is
currently being considered by the Joint Oireachtas
Committee on Justice, Equality, Defence and
Women’s Rights. Among the proposed
amendments are:
■ provisions for creating criminal offences in
relation to participation in criminal
organisations
■ proposals to strengthen the provisions on the
imposition of the 10-year mandatory
minimum sentence for drug trafficking
■ new offences of supplying drugs to prisoners
■ provisions in relation to a Drug Offenders
Register
■ new provisions to deal with anti-social
behaviour such as anti-social behaviour orders
■ provisions to raise the age of criminal
responsibility to 10 years.
Other legal developments
Action 27 of the National Drugs Strategy
2001–2008 obliges the Garda Síochána, the Health
Boards and vintner representative bodies to
‘prepare guidelines… for publicans and night-club
owners regarding drug dealing on, or in the vicinity
of, their premises. These guidelines should set out
clearly the actions which the owner of the premises
should take in response to drug dealing…’ In June
2005 an information booklet, entitled Guidelines
regarding drug dealing on or in the vicinity of licensed
premises,2 was launched with the aim of addressing
Action 27. The guidelines were drawn up by the
Garda Síochána, with the co-operation of the
Licensed Vintners Association, the Irish Nightclub
Industry Association, the Vintners Federation of
Ireland, the Department of Health and Children
and the Irish Hotels Federation. The guidelines
cover such matters as the law in relation to drug
issues, the legal conditions and appropriate
procedures for the conducting of searches of
persons entering premises, signs of drug misuse by
customers, what to do if drugs are found, first aid,
and the monitoring of queues. (Johnny Connolly)
1. Oireachtas Joint Committee on Justice, Equality,
Defence and Women's Rights (2005) Report on
Community Policing, April 2005. Dublin:
Stationery Office.
2. An Garda Síochána and others (2005) Guidelines
regarding drug dealing on or in the vicinity of
licensed premises. Dublin: An Garda Síochána.
Legal briefing (continued)
Jane Carrigan was recently awarded a distinction by Trinity College for her MSc in Applied
Social Research thesis. Jane worked with the DMRD earlier this year and completed a study on
harm reduction in prisons which involved interviews with ex-prisoners. We want to
congratulate Jane and wish her well in her career.
Congratulations
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On 16 August 2005 the Irish Medicines Board (IMB)
issued a warning that prolonged use of over-the-
counter (OTC) medicinal products containing codeine
may cause addiction. The IMB has instructed
companies producing OTC codeine-containing
medicinal products to amend the product information
leaflets to state that there is a possibility of physical and
psychological dependence associated with prolonged
use of these products. Nurofen Plus and Solpadeine are
examples of codeine-containing products. www.imb.ie 
In September 2005 the Childhood Development
Initiative (CDI) published its 10-year strategy, A Place
for Children. The culmination of two years’ work, the
strategy seeks to improve the health, safety and
learning of the children (aged 0 to 13) of Tallaght West
and to increase their sense of belonging to their
community.  Under the broad outcomes of improved
health and safety, the strategy identifies as a ‘specific
outcome’, that future cohorts of 12 and 13-year-olds
transferring to secondary school will ‘be using fewer
drugs, alcohol and other substances’. Activities to
achieve this and the nine other specific outcomes listed
in the strategy include early childhood care and
education for all children; the integration of services in
schools and in child and family centres; new services
targeted at the identified needs of children; improving
the quality of existing provision; and advocating for the
reduction of major stresses on children and families.
On 6 October 2005 the Secure America and Orderly
Immigration Act, introduced in the US Senate and
Congress in May 2005, was the subject of a motion of
support in Dáil Éireann. If adopted, the Act will open a
route to legality for undocumented people living in the
US, including Irish citizens (estimated to number
anywhere between 5,000 and 50,000). During the Dáil
debate, concern was expressed for the levels of stress
experienced by these Irish citizens owing to their
constant fear of detection, need for secretiveness and
sense of isolation. Irish immigration centres in the US
have reported a rise in stress-related problems and
substance misuse among these clients, and are
responding by developing in-house counselling services.
The Irish government provides financial support for the
Irish immigration centres. www.oireachtas.ie 
On 11 October 2005 MEAS held its third 'Alcohol and
Society' annual conference. The theme was 'Alcohol
and the Community'. The aims of the conference
included encouraging informed debate on community-
based alcohol initiatives and promoting best practice in
regard to integrated, community-based alcohol
initiatives. www.meas.ie 
On 17 October 2005 a Green Paper on Mental
Health (COM [2005] 484 final) was adopted by the
European Commission. The Green Paper forms the
basis for a public consultation on how to tackle
mental health and promote psychological well-being
in the EU. Misuse of alcohol, drugs and other
psychoactive substances is identified in the Green
Paper as a risk factor for, or a consequence of, mental
health problems, and preventive action in relation to
alcohol and drugs misuse is proposed as one measure
to improve the mental health of the European
population. Comment on the Green Paper is invited
by 31 May 2006.
www.europa.eu.int/comm/health/ph_determinants/life_
style/mental/green_paper/consultation_en.htm 
On 19 October 2005 the Independent Monitoring
Commission released its seventh report. In relation to
paramilitary groups and organised crime, the
Commission concluded that because of paramilitary
involvement, organised crime (including drug dealing)
is the biggest long-term threat to the rule of law in
Northern Ireland.
www.independentmonitoringcommission.org 
In October 2005 European Anti-Poverty Network
(EAPN) Ireland launched its new website. The website
carries a series of pages on policy issues relating to
poverty, including drugs. EAPN Ireland is the Irish
national network of the European Anti-Poverty
Network, which links groups fighting for the eradication
of poverty across the EU. The Irish network’s roles
include empowering network members through
information and training; policy development and
advocacy in relation to the eradication of poverty at
both national and EU level; and promoting networking
between anti-poverty groups across the EU.
www.eapn.ie 
In October 2005 the Criminal Assets Bureau (CAB)
Annual Report 2004 was laid before the Houses of the
Oireachtas. The Report states that 80% of the High
Court orders obtained under the Proceeds of Crime Act
1996 during 2004 were directly connected to the
proceeds of drug trafficking. The Report also notes that
2004 was the first year in which monies (€275,875.43),
previously frozen by court orders under Section 3 of the
Proceeds of Crime Act 1996, were remitted to the
Minister for Finance for the benefit of the central fund.
In outlining new developments, the Report details how
Action 9 of the National Drugs Strategy, ‘to target 
the assets of middle-ranking criminals involved in 
drug-dealing’, has been implemented. The CAB, along
with the Garda National Drugs Unit, has trained one
member of the Garda Síochána from each of the 25
Garda divisions as a divisional profiler in criminal assets.
A course was delivered, in association with the Garda
College, covering all areas of assets forfeiture. These
divisional criminal assets profilers complement and
enhance the CAB’s role in relation to identifying, tracing
and seizing criminal assets of persons engaged in
criminal conduct. www.justice.ie 
In October 2005 the CityWide Drugs Crisis Campaign
published Drug Rehabilitation – A View from the
Community. This report contains the results of a
CityWide survey undertaken in July 2005 on the work of
special Community Employment projects delivering
drug rehabilitation programmes. It outlines the key
elements of a model Drug Rehabilitation Service that is
community-based, integrated, multi-agency and client-
centred. www.citywide.ie 
(Compiled by Brigid Pike)
In brief
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Problem drug use and the evidence-based
approach to treatment
In the next few issues of Drugnet Ireland we will be
looking at the subject of evidence-based medicine
(EBM) and its current and potential role in the
treatment of problem drug use. This article provides
a very brief overview of the concept of EBM and
points to where the evidence can be found.
What is evidence-based medicine?
EBM is an approach to clinical decision making
that relies heavily on high-quality research
evidence. The definition below neatly describes the
central principles of a practice which follows the
EBM approach.
Evidence based clinical practice is an approach to
clinical decision making in which the clinician
uses the best evidence available, in consultation
with the patient, to decide upon the option
which suits that patient best.1
It is important to note here that an evidence-based
approach is not simply an unmediated application
of evidence from research; the experience and
judgement of the clinician providing treatment and
the expectations, needs and background of the
patient, client or carer are also essential evidence
and play a role in clinical decision making.
Where does the evidence come from?
Evidence-based practice relies on findings based on
a number of research tools:
Systematic reviews identify all the research evidence
on a topic, appraise it for quality and attempt to
draw conclusions from the evidence available.
Randomised control trials are studies in which a
group of subjects receiving an intervention is
compared with a control group. Both groups are
randomly selected. 
Cohort studies are those in which patients who
presently have a certain condition and/or are
receiving a particular treatment are followed up
over time and compared with another group who
are not affected by the condition or treatment
under investigation.
Other research tools include case-controlled studies
and qualitative studies.
Where is the evidence found?
Databases
Finding evidence may involve searching a number
of databases and other sources. The Cochrane
Collaboration is responsible for synthesising
evidence-based research in the form of systematic
reviews, which are made available through the
Cochrane Database of Systematic Reviews. There
are also several bibliographic databases covering all
the major medical and health fields. These include
Medline, the database of the National Library of
Medicine (USA); EMBASE, the Excerpta Medica
Database; and PsycINFO, the database of the
American Psychological Association. A database of
particular relevance to the addictions field is ETOH,
the Alcohol and Alcohol Problems Science
Database of the US National Institute on Alcohol
Abuse and Alcoholism. Unfortunately, this database
is not currently being updated and, while it is still
available online, for free, no new records have
been added since 2004. Another very useful source
is Clinical Evidence, an online directory published by
the BMJ and updated monthly.
Clinical guidelines
Clinical practice guidelines are another important
facet of the knowledge base required by clinicians
seeking evidence to support decisions. These
guidelines are systematically developed statements
designed to assist in patient and physician clinical
decision making for specific clinical circumstances.
They are prepared using clinical experience, expert
knowledge and research evidence and developed
using a consensual approach often involving
treatment providers and patient groups as well as
clinicians.
Examples of organisations that provide online
access to clinical guidelines are the UK National
Institute for Health and Clinical Excellence
(www.nice.org.uk) and Canada’s CMA Infobase
(http://mdm.ca/CPGSNEW/CPGS/INDEX.ASP).
Guidelines Finder is a special service available
through the National Electronic Library for Health
which holds details of over 1400 guidelines in 
the UK.
Practice guidelines for the medical treatment of
problem substance use are readily available but
this is, of course, only part of the picture. Finding
guidelines which describe best practice in other
forms of treatment, including psychosocial
treatment, is much more difficult and this evidence
is not often available through the sources outlined
above. 
Treatment approaches to problem drug use need
to address not only the medical or physical
manifestation of the problem; they must also
consider social, psychological, economic and other
The National Documentation Centre on
Drug Use
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The National Documentation Centre on Drug Use (continued)
factors. 
It might appear that the principles of EBM, with its
emphasis on providing support to clinical decision
making, has limited applicability in the addictions
field. However, the concept of EBM is receiving
increasing attention in scholarly literature in the field.
Furthermore, studies examining the efficacy and
benefits of treatment programmes have identified
the evidence-based approach as important in
achieving successful outcomes.
Service providers and planners are well aware of the
emphasis on efficiencies in health services and the
need to demonstrate the economic benefits. A
recent systematic review of American research on
treatment for problem drug and alcohol use
demonstrated that treatment programmes have
produced significant social, economic and health
benefits.2 The review found that reduction in drug
and alcohol use, and consequent improvements in
health and social function of the individual receiving
treatment, are most marked when the treatment
used is evidence based. This underlines the
importance of ensuring that those responsible for
designing, implementing and delivering treatment
services have access to the evidence base. 
Future issues of Drugnet Ireland will look at how
the concept of EBM is treated in addiction
literature and at the role of researchers, librarians
and service planners in turning evidence into
knowledge which can be used to reduce drug-
related harm. (Brian Galvin)
1.  Muir Gray JA (2003) Evidence based health care:
how to make health policy and management
decisions. 2nd edn. Edinburgh: Churchill
Livingstone.
2.  References to this study and other research and
sources of evidence are available with the
online version of this article on the NDC
website at www.hrb.ie/ndc.
Directory of courses and training
programmes
The National Documentation Centre on Drug
Use is compiling a Directory of courses and
training programmes in the area of drug use in
Ireland. 
The Directory will contain information on: 
■ Short courses aimed at providing basic
information and/or raising awareness of drug
misuse among a general target audience
■ Longer courses aimed at providing
information, raising awareness and
developing skills among those whose paid
or voluntary work brings them into contact
with drug use.
■ Courses leading to a professional or
academic qualification 
■ Courses in drug misuse aimed at young
people
■ In-service training for professionals and
other vocational groups working in the
field of drug misuse or related areas
The Directory will be published in summer
2006 and will be available on the NDC website. 
If you deliver a course that you think should be
included in the new Directory, please contact:
Mary Dunne
Information Officer
t +353 1 6761176 ext 180
e mdunne@hrb.ie
Christmas Hours
The NDC will close for Christmas on Friday 23
December at 1.00 pm.
It will open again on Tuesday 3 January at 9.15 am.
Students from the TCD Diploma in Addiction Studies on a visit to the NDC
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Books
Drugs and human behavior 
Grilly DM Pearson 2006, 444 pp.
ISBN 0 205 44362 1
Although the use of
psychoactive drugs
has a long history,
the systematic study
of the relationships
between drugs and
psychological
processes –
psychopharmacology
– is quite new. The
purpose of this book
is to introduce the
reader to this field,
with special emphasis
on the relationships between drugs, their
mechanisms of action in the nervous system, and
human behaviour. The text is written in concise,
jargon-free prose for students of psychology,
nursing, chemistry or biology who are interested in
research associated with drugs and their use in
social, recreational or therapeutic settings, or who
intend to specialise in related clinical fields. 
Chapter 1 deals briefly with the field of
pharmacology from a historical perspective.
Chapters 2 and 3 acquaint the student with the
principles and mechanisms behind the actions of
drugs that can be generalised to all drugs.
Chapters 4 and 5 review the nervous system,
through which psychoactive drugs induce their
effects. Chapter 6 discusses the general processes
behind drug tolerance, drug abuse and drug
dependence. This chapter contains a section on
general factors in treatment for drug dependency.
Chapters 7 to 11 classify, describe and discuss the
actions and effects of drugs, such as alcohol,
hypnotics, amphetamines, cocaine, opioids and
hallucinogens, commonly used in our culture for
social and recreational purposes, often leading to
drug abuse and dependence. Each of these
chapters contains a section on the current
treatment for abuse of the drugs discussed and
provides a number of approaches for prevention
and reduction of their consequences. Chapters 12
to 14 describe and discuss the actions and effects
of drugs used primarily in the treatment of mental
and emotional disturbances. A list of websites for
further information is given at the end of each
chapter. The book has an updated Drug Name
Index, a comprehensive bibliography and a
general index.
Successful prevention and youth development
programmes: across borders
Ferrer-Wreder L, Stattin H, Cass Lorente C, Tubman
JG and Adamson L 
Kluwer Academic / Plenum Publishers 2004, 339 pp.
ISBN 0 306 48176 6
Written collaboratively by
American and Swedish
researchers, this book is a
compilation of the latest
work in the field of
prevention science. It is
essentially a review of a
sample of scientifically
evaluated programmes of
intervention that are
aimed at either
promoting youth
development or
ameliorating the long-
term consequences of problem behaviours in
young people. In selecting programmes for the
book, the authors ensured that work in
intervention from both North America and Europe
was included; they also preferred to include
intervention programmes that had involved the
participants in their design, implementation and
maintenance. The book includes prevention and
promotion programmes across the age range from
pre-schoolers to adolescents, and covers
interventions in the family, in the school and in the
community. 
The book is in three parts: the Introduction forms
Part I, and contains an analysis of selected topics,
principles and debates within the prevention and
youth development literatures. Part II, the Review,
is made up of six chapters providing examples of
good prevention practice in family, school and
community contexts. These chapters contain a
‘best evidence synthesis’ of salient research
literatures and a review of ‘cross-context
interventions’. The last of these chapters
summarises the findings of an interview study with
programme developers and implementers who
have taken part in cross-national intervention trials.
Part III, Resource Guide, consists of three chapters:
(1) a Glossary of key terms that are set in bold
type the first time they appear in the text; 
(2) Programme Examples, gives programme
summaries in some detail, which provide readers
with a road map for the development of
intervention programmes and policies; (3) Web
Resources, is intended to give the reader the tools
to explore the most current intervention-related
literature. These last two chapters are designed to
encourage further independent analysis of the
research literature. 
Recent publications
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Journal articles
The following abstracts are from a selection of
articles relating to the drugs situation in Ireland
recently published in Irish and international
journals.
In-patient treatment of opiate dependence:
medium-term follow-up outcomes 
Smyth BP, Barry J, Lane A, Cotter M, O’Neill M,
Quinn C and Keenan E
British Journal of Psychiatry 2005; 187: 360–365
The outcome for opiate-dependent patients
seeking abstinence is unclear in this era of
improved access to methadone maintenance. 
The aim of this study was to measure the outcome 
2—3 years after in-patient treatment. Opiate-
dependent patients admitted with a goal of
abstinence were followed-up. A structured
interview examined drug use and treatment in the
preceding month. Five patients had died and 109
(76%) of the remaining 144 were interviewed.
Fifty per cent (54 patients) reported recent opiate
misuse and 57% (62) were on methadone
maintenance. Twenty-three per cent (25 patients)
were abstinent (i.e. neither using opiates nor on
methadone maintenance). Abstinence was
significantly associated with completion of the 
6-week in-patient treatment programme and
attendance at out-patient after-care, and
negatively associated with a family history of
substance misuse. In conclusion, abstinence
remains an attainable goal. As the principal
influence on outcome was treatment adherence,
inpatient services should seek to enhance rates of
programme completion. After-care should be
provided to patients. We caution against use of
pre-treatment patient characteristics as criteria for
prioritising access to in-patient treatment.
An exploration of prisoners’ and prison staff's
perceptions of the methadone maintenance
programme in Mountjoy Male Prison, Dublin,
Republic of Ireland
Carlin T
Drugs: Education, Prevention & Policy
2005; 12(5): 405–416
This study, which was based in Ireland's main
committal prison, used semi-structured interviews
and a focus group to explore the perceptions of
staff and prisoners towards methadone
maintenance within the prison setting. Although
the research subjects identified advantages and
disadvantages associated with methadone
prescribing within the prison, they were generally
positive in their assessment of Mountjoy's
methadone programme. Prisoners perceived it as
leading to an improvement in their relationships
with their families, while staff viewed it as
facilitating a more stable and safer working
environment. However, although prisoners’ use of
heroin had reportedly declined since the advent of
the methadone maintenance programme in the
prison, their use of other drugs had not. There
were negative views expressed by both groups
about the manner in which methadone is
dispensed within the prison, and also because
methadone was viewed as being as addictive as
heroin. Regarding perceptions of the purpose of
methadone maintenance, there was a spectrum of
interpretations among the interviewees. Five
purposes were identified. These were: (1) to ensure
continuity of harm-reduction policies from the
community; (2) to reduce the supply of heroin in
the prison; (3) to prevent needle sharing and the
spread of blood-borne infections; (4) to treat
heroin addiction; and (5) to control prisoners and
maintain order and discipline within the prison.
Apropos the latter, there was a widely held
perception within the total sample that this latent
function of methadone maintenance could be seen
as of greater importance than the more
conventional harm-reduction functions that were
also identified.
Guidelines for the management of hepatitis C in
general practice: a semi-qualitative interview
survey of GPs’ views regarding content and
implementation
Cullen W, O’Leary M, Langton D, Stanley J, 
Kelly Y and Bury G
Irish Journal of Medical Science 2005; 
174(3): 32–37
Hepatitis C is a common infection among people
who attend GPs for methadone maintenance
treatment. The aim of this survey was to determine
the views of GPs on clinical guidelines for the
management of hepatitis C among current or
former injecting drug users, in advance of their
implementation. A purposive sample of 14 GPs
(10% of the total number prescribing methadone
at the time the guidelines were developed) was
invited to review a pre-publication draft of the
guidelines; these participants were interviewed
regarding content, presentation, perceived barriers
to implementation and suggested interventions to
facilitate effective implementation of the
guidelines. Survey results showed that GPs found
the guidelines useful, but suggested that aspects of
presentation should be clarified. Organisational
issues were identified as the principal barriers to
effective implementation; the provision of
additional nursing support was the principal
intervention suggested to facilitate
implementation. The paper concludes that
interviewing intended recipients may be an
important step in ensuring that clinical practice
guidelines are effectively implemented.
Recent publications (continued)
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‘Scripting’ risk: Young people and the
construction of drug journeys
Mayock P
Drugs: education, prevention & policy
2005; 12(5): 349–368
The concept of risk, and its centrality to social life,
is theoretically much discussed within late
modernity. This paper examines young people's
drug use and their drug transitions within a
framework of risk drawing on findings from a
longitudinal ethnographic study of drug use
among young people in a Dublin inner-city
community. Fifty-seven young people aged
between 15 and 19 years, including non-users,
recreational, and problematic drug users, were
recruited into the study in 1998. Contact was 
re-established with 42 of the study's participants 
in 2001. Individual interviews and focus group
discussions, supported by prolonged participation
within the study site, were the primary methods of
data collection. Drawing on the young people's
situated accounts of their drug-taking events,
routines, and practices across time, the findings
highlight the complex social negotiations involved
in the construction of drug journeys. Analyses of
change in drug use behaviour over the study
period demonstrate that drug transitions unfold
alongside dynamic and changing perceptions of
safety and risk. Responses to ‘risk’ within youth
drug scenes were contextually shaped, open to
situational revision over time, and, in many
instances, drug taking was habitual, not calculated.
Put differently, young people ‘script’ risk as they
gain experience in the world. The type of calculus
involved in the making of drug journeys is fluid
and relational, socially contingent rather than
static, and subject, at times, to constrained agency
linked to social and economic marginalisation. It is
argued that models of risk that rely on
individualistic and rationalistic assumptions
struggle to accommodate the fluidity and
contradiction that characterises much drug use.
Implications for strategies and initiatives aimed at
reducing drug-related harm are discussed.
The impact of paramilitary violence against a
heroin-user community in Northern Ireland: a
qualitative analysis
Higgins K and Kilpatrick R
International Journal of Drug Policy
2005; 16(5): 334–342
Over the past decade, Northern Ireland has
witnessed the cessation of conflict and the
emergence of the ongoing peace process. It is now
dealing with new patterns of crime and with social
problems either ignored or suppressed during the
years of the so-called ‘Troubles’. A key example is
heroin and injecting drug use. Systematic beating,
exiling and torture by paramilitaries remain
pervasive in many communities. Drawing on data
from a qualitative study examining the emergence
of the heroin scene in Ballymena, this paper
presents findings that illustrate the impact of
paramilitary violence on a heroin-using
community. The paper describes, both from the
perspective of the heroin users and the
professionals seeking to help them, the violence
and intimidation perpetrated by the paramilitants.
The impact this rough justice has on their day to
day lives is explored, as well as the difficulties it
presents in influencing their decisions to utilise
services such as harm reduction initiatives. The
paper provides context by summarising available
evidence on the extent of heroin use in Northern
Ireland and presenting a brief account of current
Northern Ireland drug policy. The historical
relationship between paramilitary groups and
communities is also briefly outlined. By way of
conclusion, the paper discusses the relationship
between wider societal transformation in Northern
Ireland and drug-use patterns and outlines how
heroin users might be assisted in dealing with the
compounded nature of the challenges facing them
as a result of the paramilitary threat.
Recreational drugs and fetal gastroschisis:
maternal hair analysis in the peri-conceptional
period and during pregnancy
Morrison JJ, Chitty LS, Peebles D and Rodeck CH
BJOG: An International Journal of Obstetrics &
Gynaecology 2005; 112(8): 1022–1025
This prospective observational study aimed to
objectively measure individual recreational drug
groups in maternal hair samples timed for the
period of conception and different stages of
pregnancy in expectant mothers with a diagnosis
of fetal gastroschisis. The study was conducted in a
tertiary level fetal medicine unit in a university
teaching hospital on a population of pregnant
women with a diagnosis of fetal gastroschisis 
(n= 22). The control group consisted of a group of
women (n= 25) with a normal fetus. Hair samples
were cut from the vertex of the head of expectant
mothers with a diagnosis of fetal gastroschisis and
a matched control group in whom the fetus was
normal. The samples were analysed by enzyme-
linked immunosorbent assay (ELISA) for individual
drug groups. Confirmatory tests using gas
chromatography with mass spectrometry (GCMS)
were used. Main outcome measures were the
presence of recreational drug compounds in hair
samples. In the group with fetal gastroschisis there
were four proven positive cases for recreational
drug abuse (18%) and there were none in the
control group. The authors concluded that the
incidence of recreational drug use in the peri-
conceptional period and the first trimester by
expectant mothers with a diagnosis of fetal
gastroschisis is 18%. This association may be linked
to the recent increase in the incidence of
gastroschisis among younger mothers. 
(Compiled by Louise Farragher and Joan Moore)
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Upcoming events
(Compiled by Louise Farragher) 
Email: lfarragher@hrb.ie
December 2005
16 December 2005
Seminar: Drug Education and Prevention
Venue: Cork 
Organised by / Contact: Regional Drugs Task
Force, Southern Region. Call David Lane or
Gemma O'Leary on +353 (0)21 492 3132.
Community Services Office, 
St Finbarr's Hospital, Cork.
Email: gemma@corkldtf.ie
Information: The focus of this seminar is to
examine current issues, to discuss approaches and
explore a way forward. Speakers include Dr Mark
Morgan, lecturer at St Patrick’s College,
Drumcondra, and Dr Shane Butler, chairman of the
Addiction Research Centre, Trinity College. This
seminar will be of particular interest to
professionals in this area of work: teachers, school
counsellors, youth workers, gardaí, special project
workers, etc. Limited places available.
January 2006
19 January 2006
Employee Drug Testing – Complying with the
Safety, Health & Welfare at Work Act 2005
Venue: Stillorgan Park Hotel, Dublin
Organised by / Contact: Caroline Cahill, EAP
Institute, 143 Barrack Street, Waterford.
Tel: +353 (0)51 855733
Fax: +353 (0)51 879626
Email: eapinstitute@eircom.net
Information: This conference aims to:
■ Outline the new duties on employers and
employees in relation to intoxicants
■ Present a comprehensive five point plan
which will address performance problems in
the workplace caused by drugs and alcohol
■ Review the European Workplace Drug Testing
Society (EWDTS) standards for drug and
alcohol testing
This conference will also be held in:
The Clarion Hotel, Limerick, on 2 February 2006
The Radisson Hotel, Cork, on 2 March 2006
February 
16–17 February
Prisons and Beyond..., 2006
Venue: Ramada Hotel, Leicester
Organised by / Contact: Alan Whittemore,
Conference Administrator
Tel: +44 (0)870 763 6139
Email: office@fdap.org.uk
www.fdap.org.uk/fdapevents/prisons2006.html
Information: ‘Prisons and Beyond…, 2006’ will
focus on drug services in custody and after release,
and is targeted at frontline staff and managers in
prisons and in the wider criminal justice field. The
conference will incorporate plenary presentations,
practical workshops and seminars, and interactive
debates.
The aims of the event are to:
■ Update frontline workers and managers on
the latest developments in the substance
misuse field, and on relevant developments
within the Home Office, NOMS and Scottish
Prisons Service;
■ Provide practical training and learning
opportunities on issues of relevance to good
practice in the treatment and management of
substance misusing offenders;
■ Provide an opportunity for staff and local
managers to give feedback about, and
contribute to the development of, policy and
practice in the delivery of drug services in
prisons and beyond;
■ Provide a networking opportunity for
frontline workers and managers from prisons
and the wider criminal justice field.
March 
9–10 March 2005
2006 National Drug Treatment Conference
Venue: Glasgow Radisson SAS Hotel, Scotland
Organised by / Contact: Exchange Supplies
Tel: +44 (0)1305 262244
Email: info@exchangesupplies.org
www.exchangesupplies.org/conferences/2006_ND
TC/intro.html
Information: Five major themes will be addressed
by the conference: marginalised groups; key
clinical issues; prison healthcare; commissioning;
and pharmacy services.
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Upcoming events (continued)
April
30 April–4 May  
17th International conference on the reduction
of drug-related harm. Hear + Now: The Peer
Conference
Venue: Vancouver, Canada
Organised by / Contact: Conference
Management Team
Tel: +1 604 688 9655 ext. 2
Fax: +1 604 685 3521
www.harmreduction2006.ca
Information: The Hear in this year’s conference
theme highlights our determination to support the
‘global dialogue’ around harm reduction. The Now
emphasises our need to act on what we learn
immediately. In specific terms, PEER represents
protection, empowerment, equality and respect –
the backbone of harm-reduction programmes. The
global sense of ‘peer’ support can and should
encompass all members of the harm reduction
community, including users and former users,
street workers, government agencies, health care
workers, policy makers, law enforcement agencies,
drug manufacturers, and the business community.
May
4–5 May
Faculty of Substance Misuse Annual Meeting
Venue: Andels Hotel, Prague
Organised by / Contact: The Royal College of
Psychiatrists. Sally Fricker, College Conference
Office.
Tel: +44 (0)20 7235 2351 ext 145
Email: sfricker@rcpsych.ac.uk
www.rcpsych.ac.uk/conferences/diary/index.htm
Drugnet Ireland mailing list
If you wish to have your name included on
the mailing list for future issues of Drugnet
Ireland, please send your contact details to
the Administrative Assistant, Drug Misuse
Research Division, Health Research Board,
Holbrook House, Holles Street, Dublin 2. 
Tel: 01 676 1176 Ext 127; Email: dmrd@hrb.ie
Among the publications issued by the
European Monitoring Centre for Drugs and
Drug Addiction (EMCDDA) are Drugnet
Europe, a quarterly newsletter, and Drugs in
focus, a series of policy briefings issued three
times a year.  Electronic versions of both
publications are available on the EMCDDA
website at www.emcdda.eu.int.  Hard copies
of current and future issues may be obtained
from the Drug Misuse Research Division at
the above address.
The documents referred to in this issue of
Drugnet Ireland are available in the National
Documentation Centre on Drug Use at the
above address. Tel: 01 676 1176 Ext 175;
Email ndc@hrb.ie
The Drug Misuse Research Division (DMRD)
of the Health Research Board is a multi-
disciplinary team of researchers and
information specialists who provide objective,
reliable and comparable information on the
drug situation, its consequences and
responses in Ireland. The DMRD maintains
two national drug-related surveillance
systems and is the national focal point for the
European Monitoring Centre for Drugs and
Drug Addiction. The Division also manages
the National Documentation Centre on Drug
Use. The DMRD disseminates research
findings, information and news in Occasional
Papers, in the Overview series and in a
quarterly newsletter, Drugnet Ireland. Through
its activities, the DMRD aims to inform policy
and practice in relation to drug use.
